Renaissance Technologies LLC Has $30,000 Holdings in Milestone Scientific Inc. (NYSE:MLSS)

Renaissance Technologies LLC cut its stake in shares of Milestone Scientific Inc. (NYSE:MLSS) by 51.5% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 43,897 shares of the company’s stock after selling 46,600 shares during the period. Renaissance Technologies LLC owned approximately 0.06% of Milestone Scientific worth $30,000 as of its most recent SEC filing.

Insider Buying and Selling at Milestone Scientific

In other Milestone Scientific news, Director Leonard Osser sold 141,913 shares of Milestone Scientific stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $0.95, for a total transaction of $134,817.35. Following the completion of the sale, the director now directly owns 4,602,506 shares of the company’s stock, valued at $4,372,380.70. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders sold 143,122 shares of company stock worth $136,026 in the last quarter. 24.75% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

MLSS has been the subject of a number of recent research reports. Benchmark initiated coverage on shares of Milestone Scientific in a research report on Thursday, October 10th. They issued a “speculative buy” rating and a $1.25 target price for the company. StockNews.com assumed coverage on Milestone Scientific in a research note on Wednesday, October 9th. They issued a “hold” rating for the company.

Milestone Scientific Price Performance

NYSE:MLSS opened at $0.85 on Tuesday. Milestone Scientific Inc. has a 1-year low of $0.52 and a 1-year high of $1.10. The business has a 50 day moving average of $0.96 and a 200 day moving average of $0.81. The company has a market capitalization of $65.72 million, a price-to-earnings ratio of -8.51 and a beta of 1.08.

Milestone Scientific (NYSE:MLSS) last issued its quarterly earnings results on Thursday, August 15th. The company reported ($0.02) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.01). Milestone Scientific had a negative return on equity of 60.78% and a negative net margin of 54.87%. The firm had revenue of $1.85 million during the quarter.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.